Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
Filed with HKEX · Stock code 6086 · · 10 pages · English
Summary by 6ix AI
It confirms the total authorized share capital and provides details on issued shares and public float sufficiency. The report indicates that there were no changes in the number of issued shares during the month. Additionally, it confirms compliance with public float requirements as of the end of the reporting period.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Fangzhou
- Adoption of share incentive scheme
- Fangzhou Releases 2026 Interim Report, Deepening "AI + Chronic Care" as a Lifetime Health Service Partner
- 2026 Interim Report
- Fangzhou Reports Sustained Revenue and Profit Growth as AI-Powered Chronic Care Strategy Gains Momentum
- Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
Follow Fangzhou into a list and get an email when it puts out news.
Follow Fangzhou